| UPSA Switzerland AG - Dafalgan 500 mg, Tabletten | | 69266 | | 01 | | Dafalgan 500 mg | | Tabletten | | N02BE01 | | Paracetamol | | 28.03.2024 | | |
| | Composition | | paracetamolum 500 mg, hypromellosum, povidonum K 90, carmellosum natricum conexum corresp. natrium 2.07 mg, cellulosum microcristallinum, glyceroli dibehenas, magnesii stearas, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Paracetamol | 500 mg |
| | | | Inactive agents | Dose |
|---|
| Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | Glyceroli Dibehenas | | | Hypromellosum | | | Magnesii Stearas | | | Povidonum K | 90 | | Pro Compresso | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 20 | | | B | | No | | 002 | 30 | 2.19 | 11.60 | B | SL | No | | 003 | 90 | | | B | | Yes | | 004 | 100 | 5.95 | 15.70 | B | SL | No |
|
|
